Ryan S. Burgos

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy”.

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3642

N/A

0DataRank · unranked

38 citations

Galen Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue +22 more

Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.08.622670

N/A

0DataRank · unranked

1 citations

Guillermo Urrutia, Andreas Due Ørskov, Hyeon Jin Kim, Seth A. Nelson, Anh Van Nguyen +20 more